Future Financial Wealth Managment LLC Makes New Investment in Abrdn Life Sciences Investors (NYSE:HQL)

Future Financial Wealth Managment LLC purchased a new position in shares of Abrdn Life Sciences Investors (NYSE:HQL) during the third quarter, HoldingsChannel.com reports. The fund purchased 2,000 shares of the company’s stock, valued at approximately $30,000.

A number of other large investors also recently bought and sold shares of HQL. B. Riley Wealth Advisors Inc. purchased a new position in shares of Abrdn Life Sciences Investors in the 1st quarter valued at $143,000. Sanctuary Advisors LLC purchased a new position in shares of Abrdn Life Sciences Investors in the 2nd quarter valued at $154,000. Wedbush Securities Inc. raised its stake in shares of Abrdn Life Sciences Investors by 8.2% in the 2nd quarter. Wedbush Securities Inc. now owns 16,673 shares of the company’s stock valued at $236,000 after acquiring an additional 1,261 shares during the period. Oppenheimer & Co. Inc. raised its stake in shares of Abrdn Life Sciences Investors by 4.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 18,414 shares of the company’s stock valued at $251,000 after acquiring an additional 814 shares during the period. Finally, Matisse Capital raised its stake in shares of Abrdn Life Sciences Investors by 243.3% in the 1st quarter. Matisse Capital now owns 34,333 shares of the company’s stock valued at $468,000 after acquiring an additional 24,333 shares during the period. Hedge funds and other institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Price Performance

Shares of HQL stock opened at $14.84 on Friday. The company’s fifty day simple moving average is $15.15 and its 200-day simple moving average is $14.34. Abrdn Life Sciences Investors has a 52 week low of $11.34 and a 52 week high of $15.90.

Abrdn Life Sciences Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Friday, August 23rd were paid a dividend of $0.49 per share. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.96 annualized dividend and a yield of 13.21%.

Abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.